Blood Transfusion - 3 2020 (May-June)
Editorial
Position paper
Original article
-
The effect of donor's characteristics on plasmapheresis products: insights for a personalised approach
-
Intravenous ferric carboxymaltose is effective and safe in patients with inflammatory rheumatic diseases
-
On the relevance of preoperative haemoglobin optimisation within a Patient Blood Management programme for elective hip arthroplasty surgery
-
Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light
-
Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease
-
Cord blood-derived platelet concentrates as starting material for new therapeutic blood components prepared in a public cord blood bank: from product development to clinical application
Review
Commentary
Letter to the Editor
-
Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?
-
A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak
-
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial
-
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"